Document is current

Any future updates will be listed below

Frontline nivolumab — CheckMate 026 ends in stalemate

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.102

Published Online: 2017-07-20

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark